Medical Device Startup HeartHero Closes Seed Round Of Funding

DENVER, July 10, 2018 /PRNewswire/ — Medical device startup HeartHero announced today that it has raised a $1.5 million seed round investment from a venture capital firm, angel investors and grant funding. Initial investments will help HeartHero build a next-generation automated external defibrillator (AED). The company, which surpassed its initial funding goal, will focus now […]

Cardiovascular Systems, Inc. to Release Fiscal 2018 Fourth-Quarter Results on July 30

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results on July 30 after market close. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its analyst day on July 31. The analyst day webcast will begin […]

Biotricity Provides Fiscal 2018 First Quarter Updates for Shareholders

REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today provided operational updates for its fiscal 2018 first quarter which ended June 30, 2018. The Company’s premier product, Bioflux, has achieved market expansion […]

Neovasc Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing

VANCOUVER, July 9, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will request a hearing before the Nasdaq Hearings Panel (the “Panel”) as the next step in the process to seeking an […]

Boston Scientific to Acquire Cryterion Medical, Inc.

MARLBOROUGH, Mass., July 5, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). The addition of this cryoballoon platform positions the company as the first to have both cryothermal […]

Lexington Biosciences Announces Results of Annual General Meeting

VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes to provide the results of its recent Annual General Meeting. The Company is pleased to announce that all matters before the Board were approved at the […]

Esperion to Host Analyst and Investor Day Event on July 10

ANN ARBOR, Mich., July 03, 2018 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced it will host an analyst and investor day in New […]

Neovasc Announces Filing of Shelf Prospectus and Form F-10 Registration Statement

VANCOUVER, July 2, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada, other than Quebec, and a corresponding shelf registration statement on Form F-10 (the “Registration Statement”) with the U.S. Securities and […]